Author

J. Pacheco

Observed names: J.M. Pacheco, Jaime Pacheco

Observed institutions: Wright State University, Dayton VA Medical Center, Universidad FUCS, University of Colorado Cancer Center, University of Colorado Anschutz

OpenAlex ID: A5109123734

LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid tumours with NRG1/ERBB gene fusions

2020 · S.V. Liu, L.C. Villaruz, et al. · Annals of Oncology · 82

976P Phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): Registrational data from DESTINY-Lung01

2022 · B.T. Li, E.F. Smit, et al. · Annals of Oncology · 7

OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Pleural Mesothelioma - NCT03126630

2023 · A.S. Mansfield, J.V. Yin, et al. · Journal of Thoracic Oncology · 3

P1.01-87 Osimertinib Acquired Resistance Mechanisms and Post-Progression Outcomes in Stage IV EGFR Positive Non-Small Lung Cancer

2019 · T. Patil, A. Dimou, et al. · Journal of Thoracic Oncology · 1

P1.14-09 Unveiling Hidden MET-Mediated Primary Alectinib Resistance in ALK-Positive Non-Small Cell Lung Cancer

2019 · A. Le, L. Tyler, et al. · Journal of Thoracic Oncology · 1

The Effect of Alcoholism on the Prognosis of Stage III and IV Non-small Cell Lung Cancer

2004 · Douglas E. Paull, Glenda M. Updyke, et al. · CHEST Journal · 1

P2.370: A First-in-Human Study of CGT4255 in Patients Who Have Advanced Solid Tumors With ERBB2 Alterations or HER2 Overexpression

2026 · D. Westphalen, S. Goldberg, et al. · Journal of Thoracic Oncology

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study

2021 · A.V. Ospina Serrano, R. Bruges, et al. · Journal of Thoracic Oncology

Extending the Duration of Efficacy of Targeted Therapies with Radiation to Oligoprogressive Disease (OPD) in Oncogene-Driven Metastatic Non-Small Cell Lung Cancer (NSCLC)

2019 · D.E. Holt, T. Patil, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 9

Citation count: 95

H-index: 3

I10-index: 1